Annual Accounts Receivable
$1.52 B
-$859.62 M-36.07%
December 31, 2024
Summary
- As of March 13, 2025, BNTX annual accounts receivable is $1.52 billion, with the most recent change of -$859.62 million (-36.07%) on December 31, 2024.
- During the last 3 years, BNTX annual accounts receivable has fallen by -$12.50 billion (-89.13%).
- BNTX annual accounts receivable is now -89.13% below its all-time high of $14.02 billion, reached on December 31, 2021.
Performance
BNTX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.52 B
+$419.79 M+38.04%
December 31, 2024
Summary
- As of March 13, 2025, BNTX quarterly accounts receivable is $1.52 billion, with the most recent change of +$419.79 million (+38.04%) on December 31, 2024.
- Over the past year, BNTX quarterly accounts receivable has increased by +$419.79 million (+38.04%).
- BNTX quarterly accounts receivable is now -89.25% below its all-time high of $14.17 billion, reached on March 31, 2022.
Performance
BNTX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BNTX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.1% | +38.0% |
| 3 y3 years | -89.1% | +38.0% |
| 5 y5 years | +10000.0% | +10000.0% |
BNTX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.1% | at low | -89.3% | +1774.8% |
| 5 y | 5-year | -89.1% | >+9999.0% | -89.3% | >+9999.0% |
| alltime | all time | -89.1% | >+9999.0% | -89.3% | >+9999.0% |
BioNTech SE Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.52 B(-36.1%) | $1.52 B(+38.0%) |
| Sep 2024 | - | $1.10 B(+1258.2%) |
| Jun 2024 | - | $81.25 M(-95.4%) |
| Mar 2024 | - | $1.77 B(-25.7%) |
| Dec 2023 | $2.38 B(-68.9%) | $2.38 B(+12.4%) |
| Sep 2023 | - | $2.12 B(-26.6%) |
| Jun 2023 | - | $2.89 B(-58.9%) |
| Mar 2023 | - | $7.03 B(-8.2%) |
| Dec 2022 | $7.66 B(-45.3%) | $7.66 B(+6.7%) |
| Sep 2022 | - | $7.18 B(-33.8%) |
| Jun 2022 | - | $10.85 B(-23.5%) |
| Mar 2022 | - | $14.17 B(+1.1%) |
| Dec 2021 | $14.02 B | $14.02 B(+14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $12.30 B(+46.6%) |
| Jun 2021 | - | $8.39 B(+198.9%) |
| Mar 2021 | - | $2.81 B(+1279.3%) |
| Dec 2020 | $203.56 M(+1425.4%) | $203.56 M(+2318.2%) |
| Sep 2020 | - | $8.42 M(-2.5%) |
| Jun 2020 | - | $8.64 M(-24.1%) |
| Mar 2020 | - | $11.37 M(-14.8%) |
| Dec 2019 | $13.34 M(-38.4%) | $13.34 M(+36.6%) |
| Sep 2019 | - | $9.77 M(-3.0%) |
| Jun 2019 | - | $10.07 M(-53.5%) |
| Dec 2018 | $21.66 M(+294.7%) | $21.66 M |
| Dec 2017 | $5.49 M(+64.2%) | - |
| Dec 2016 | $3.34 M | - |
FAQ
- What is BioNTech SE annual accounts receivable?
- What is the all time high annual accounts receivable for BioNTech SE?
- What is BioNTech SE annual accounts receivable year-on-year change?
- What is BioNTech SE quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BioNTech SE?
- What is BioNTech SE quarterly accounts receivable year-on-year change?
What is BioNTech SE annual accounts receivable?
The current annual accounts receivable of BNTX is $1.52 B
What is the all time high annual accounts receivable for BioNTech SE?
BioNTech SE all-time high annual accounts receivable is $14.02 B
What is BioNTech SE annual accounts receivable year-on-year change?
Over the past year, BNTX annual accounts receivable has changed by -$859.62 M (-36.07%)
What is BioNTech SE quarterly accounts receivable?
The current quarterly accounts receivable of BNTX is $1.52 B
What is the all time high quarterly accounts receivable for BioNTech SE?
BioNTech SE all-time high quarterly accounts receivable is $14.17 B
What is BioNTech SE quarterly accounts receivable year-on-year change?
Over the past year, BNTX quarterly accounts receivable has changed by +$419.79 M (+38.04%)